Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X5ZO
|
||||
Former ID |
DCL001121
|
||||
Drug Name |
SSR-162369
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 1 | [548129] | ||
Company |
Sanofi-Aventis
|
||||
Structure |
Download2D MOL |
||||
Formula |
C27H33N5O2
|
||||
Canonical SMILES |
CC(=CCN1C(=NC2=C1C(=O)N(C(=C)N2C)CC(=O)C3=CC=CC=C3)C4CC<br />C5C4CCN5)C
|
||||
InChI |
1S/C27H33N5O2/c1-17(2)13-15-31-24-26(29-25(31)21-10-11-22-20(21)12-14-28-22)30(4)18(3)32(27(24)34)16-23(33)19-8-6-5-7-9-19/h5-9,13,20-22,28H,3,10-12,14-16H2,1-2,4H3/t20-,21?,22+/m0/s1
|
||||
InChIKey |
PBLJWGCWKPKYPH-JAFNVKOHSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [537022] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.